跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
颇得斯安 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Mesalazine Sustained-release Tablets
Approved
化学药品
Mesalazine Sustained-release Tablets
Ferring GmbH
🇨🇳 National Medical Products Administration
Approval Date
Mar 20, 2023
Approval ID
1xpa1QJF4iC
Company
Ferring GmbH
Type
化学药品
Approval Details
Approval Id
1xpa1QJF4iC
Approval Number
国药准字HJ20181183
Generic Name
美沙拉秦缓释片
Generic Name En
Mesalazine Sustained-release Tablets
Trade Name
颇得斯安
Drug Type
化学药品
Dosage Form
片剂
Strength
0.5g
Reg Date
2023-03-20
Expired Date
2028-03-19
Company Name
Ferring GmbH
Production Company Name
Ferring International Center Sa
Company Detail Path
/organization/ferring-gmbh
Production Company Detail Path
/organization/ferring-international-center-sa
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Mar 20, 2023
Approval ID
1xpa1QJF4iC
Type
化学药品
Back to NMPA Approvals